Lv3
320 积分 2022-09-13 加入
Idarubicin versus Epirubicin in Transarterial Chemoembolization for Barcelona Clinic Liver Cancer Stage B Hepatocellular Carcinoma: An Open-label, Randomized, Phase IV Trial
3天前
已完结
Deep Learning Radiopathomics Models Based on Contrast-enhanced MRI and Pathologic Imaging for Predicting Vessels Encapsulating Tumor Clusters and Prognosis in Hepatocellular Carcinoma
1个月前
已完结
Evaluating the Benefits of TACE Combined with Lenvatinib Plus PD-1 Inhibitor for Hepatocellular Carcinoma with Portal Vein Tumor Thrombus
1个月前
已完结
Spatial immune scoring system predicts hepatocellular carcinoma recurrence
2个月前
已完结
Evaluating the Benefits of TACE Combined with Lenvatinib Plus PD-1 Inhibitor for Hepatocellular Carcinoma with Portal Vein Tumor Thrombus
2个月前
已完结
Comparison of tumor response and outcomes of patients with hepatocellular carcinoma after multimodal treatment including immune checkpoint inhibitors – a systematic review and meta-analysis
2个月前
已完结
Endothelial DGKG promotes tumor angiogenesis and immune evasion in hepatocellular carcinoma
2个月前
已完结
Transcatheter arterial chemoembolization combined with radiofrequency ablation can improve survival of patients with hepatocellular carcinoma with portal vein tumour thrombosis: Extending the indication for ablation?
3个月前
已完结
Clinical evaluation of percutaneous endovascular radiofrequency ablation for portal vein tumor thrombus: experience in 120 patients
3个月前
已完结
Comprehensive review of hepatocellular carcinoma with portal vein tumor thrombus: State of art and future perspectives
3个月前
已完结
皖公网安备34019202002308
